About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Atlanta | 410 Studies

Clinical Trials Breast CancerAtlanta

Breast Cancer Clinical Trials in Atlanta

Find 410 clinical trials for breast cancer near Atlanta, Georgia. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Atlanta

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 410 trials

RecruitingA Study of LY4257496 in Participants With Cancer (OMNIRAY)The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relevant standard of care (SOC) combination therapy in…NCT07114601·Duarte, California and 32 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedWhole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast CancerRSR13 (efaproxiral) is a radiation sensitizer that has shown positive results in a Phase 3, randomized clinical trial of patients with brain metastases.NCT00083304·Phoenix, Arizona and 93 others

CompletedVeliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid CancerThis phase I trial is studying the side effects and best dose of veliparib when given together with carboplatin and paclitaxel in treating patients with advanced solid cancer.NCT00535119·Duarte, California and 6 others

RecruitingEvaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical TrialThis research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 or BRCA 2 mutation.NCT03990896·San Francisco, California and 6 others

RecruitingA Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid TumorsA Study of Emi-Le in Participants with Solid TumorsNCT05377996·Phoenix, Arizona and 25 others

TerminatedAn Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced MalignanciesThis is an open-label study of INCB047986 given to two distinct groups of patients (Group 1 and Group 2) with advanced malignancies.NCT01929941·Atlanta, Georgia and 2 others

CompletedA Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast CancerThe goal of this study was to determine the effect on overall survival and progression free survival by adding iniparib (BSI-201/SAR240550) to the combination of…NCT00938652·Birmingham, Alabama and 101 others

TerminatedLetrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by SurgeryRATIONALE: Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes.NCT00651976·Atlanta, Georgia and 4 others

RecruitingA Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsThis study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid…NCT07488676·Birmingham, Alabama and 20 others

CompletedA Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast CancerThe Objectives of this study: The primary objective of the study was to evaluate progression-free survival (PFS) (defined as the number of days between the date of randomization…NCT02370238·Mobile, Alabama and 76 others

CompletedA Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb20717, to describe safety and tolerability, to assess PK and…NCT03517488·Los Angeles, California and 16 others

Active not recruitingDoxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerThis randomized phase III trial studies doxorubicin hydrochloride, cyclophosphamide, and paclitaxel to see how well they work with or without bevacizumab in treating patients with…NCT00433511·Anniston, Alabama and 841 others

Active not recruitingAn Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer…NCT05952557·Dothan, Alabama and 660 others

Active not recruitingTrial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.Phase 1b/2 open-label trial of 225Ac-DOTATATE (RYZ101) in subjects with ER+, HER2-negative unresectable or metastatic breast cancer expressing SSTRs.NCT06590857·Phoenix, Arizona and 30 others

CompletedA Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.The purpose of the study is to determine if ABT-751 will decrease tumors, and determine how long the tumor shrinkage can be maintained in patients with breast cancer after having…NCT00063102·Miami, Florida and 7 others

Active not recruitingDNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive, HER-2 negative breast cancer (DARE)NCT04567420·Tucson, Arizona and 18 others

TerminatedInteraction of Docetaxel and Lonafarnib in Patients With Advanced CancerTo determine the molecular interaction in tumor samples between docetaxel and lonafarnib.NCT00288444·Atlanta, Georgia

CompletedTestosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor TreatmentThis randomized phase III trial studies testosterone to see how well it works compared to placebo in treating postmenopausal patients with arthralgia (joint pain) caused by…NCT01573442·Anchorage, Alaska and 528 others

CompletedDocetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of breast cancer cells, either by killing the cells or by stopping them from dividing.NCT01547741·Anchorage, Alaska and 914 others

CompletedDigital Mammography Screening Trial (ACRIN6652)RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for cancer.NCT00008346·Los Angeles, California and 31 others

PreviousPage 7 of 21Next

Other Conditions in Atlanta

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma